4-(5-Chlorothiophen-2-yl)-1,3-thiazol-2-amine → HCID 10296980, compound
Reaction equation
[Cl:1][C:2]1[S:6][C:5]([C:7]2[N:8]=[C:9]([NH2:12])[S:10][CH:11]=2)=[CH:4][CH:3]=1.[Cl:13][C:14]1[CH:19]=[C:18]([Cl:20])[CH:17]=[C:16]([CH3:21])[C:15]=1[S:22](Cl)(=[O:24])=[O:23]>>[Cl:13][C:14]1[CH:19]=[C:18]([Cl:20])[CH:17]=[C:16]([CH3:21])[C:15]=1[S:22]([NH:12][C:9]1[S:10][CH:11]=[C:7]([C:5]2[S:6][C:2]([Cl:1])=[CH:3][CH:4]=2)[N:8]=1)(=[O:24])=[O:23]Participants
3
Procedure
The title compound was prepared from 4-(5-chloro-2-thienyl)-1,3-thiazol-2-amine (METHOD H) and 2,4-dichloro-6-methylbenzenesulfonyl chloride as described in the synthetic METHOD B to give a white solid (19.5 mg) with purity >90%. MS (pos) m/z 439.0, 441.0.
Sources & evidence
- ORD record
- ord-e7da925ee378414594da373d98741782
- Source dataset
- uspto-grants-2006_11
- Patent number
- US07132436B2
Reaction notes
Loading…